Income Tax Expense (Benefit) in USD of QLY Biotech Group Corp. from 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
QLY Biotech Group Corp. quarterly and annual Income Tax Expense (Benefit) history and change rate from 2020 to Q1 2023.
  • QLY Biotech Group Corp. Income Tax Expense (Benefit) for the quarter ending 28 Feb 2023 was $0.
  • QLY Biotech Group Corp. annual Income Tax Expense (Benefit) for 2022 was $0.
  • QLY Biotech Group Corp. annual Income Tax Expense (Benefit) for 2021 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

QLY Biotech Group Corp. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $0 01 Dec 2022 28 Feb 2023 10-Q 13 Apr 2023 2023 Q2
Q4 2022 $0 01 Sep 2022 30 Nov 2022 10-Q 13 Jan 2023 2023 Q1

QLY Biotech Group Corp. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $0 $0 01 Sep 2021 31 Aug 2022 10-K 14 Dec 2022 2022 FY
2021 $0 $0 01 Sep 2020 31 Aug 2021 10-K 14 Dec 2022 2022 FY
2020 $0 01 Sep 2019 31 Aug 2020 10-K 22 Nov 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.